Bryan Blanck
Podiatrist · Ada, OKNPI 1215906276
Payments from drug & device makers
What this record shows
This record is dominated by education: $972 of the $1,155 with a category attached, or 84.2%. Pylant Medical accounts for 84.2% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $987 and has fallen 97.8% since, to $21 in 2025. That places this record below the midpoint for podiatrist clinicians in OK, where the typical reported total is $1,579.
Across 9 payments — averaging $128.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pylant Medical$972
- Asahi Intecc USA, Inc.$59
- Paratek Pharmaceuticals, Inc.$37
- Bsn Medical Inc$21
- Averitas Pharma Inc.$21
- Orthofix Medical, Inc.$15
- plus $29 from 2 others
What the payments were for
- Food & beverage$18316%
- Education$97284%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pylant Medical | 1 | $972 |
| Asahi Intecc USA, Inc. | 1 | $59 |
| Paratek Pharmaceuticals, Inc. | 2 | $37 |
| Bsn Medical Inc | 1 | $21 |
| Averitas Pharma Inc. | 1 | $21 |
| Orthofix Medical, Inc. | 1 | $15 |
| Organogenesis Inc. | 1 | $15 |
| Treace Medical Concepts, Inc. | 1 | $14 |
How this compares
$1,155 in reported general payments places this provider in the 40th percentile of 54 podiatrist providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 71 | $3,413 |
| Gabapentin | 159 | $1,909 |
| Pregabalin | 90 | $1,337 |
| Terbinafine Hcl | 75 | $1,155 |
| Celecoxib | 28 | $871 |
| Oxaprozin | 14 | $723 |
| Duloxetine Hcl | 33 | $554 |
| Meloxicam | 67 | $537 |
| Doxycycline Hyclate | 23 | $471 |
| Mupirocin | 51 | $442 |
| Cefdinir | 20 | $393 |
| Diclofenac Sodium | 24 | $364 |
| Amitriptyline Hcl | 28 | $334 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Ada
- Aerial AveryAda$13K
- David CavallaroOklahoma City$22K
- Ahmed BukshEdmond$17K
- Patricia BoehleOklahoma City$10K
- Kevin DuxMuskogee$8K
- Barinder BassiTahlequah$7K
- Greg RohdeNorman$7K
- Thomas WicksChickasha$6K
- Tera SantistevanSapulpa$5K
- James StoughEnid$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.